We are a fully integrated lab-to-market global enterprise with end-to-end capabilities across the biosimilars value chain. This allows us to directly manage business strategy, strengthen customer engagement, and respond swiftly to the evolving needs of healthcare systems worldwide, taking us closer to our most important stakeholder — our patients. Strategic partnerships, localized commercial models, and a deep understanding of regional healthcare needs have strengthened our ability to deliver impactful and sustainable solutions across Advanced and Emerging Markets.